|
| 37861205 | Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial. | Int J Cancer | 2024 |
| 37861205 | Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial. | Int J Cancer | 2024 |
| 36287144 | Recruitment Challenges of a Colorectal Cancer Screening Dissemination Study. | Nurs Res | 2023 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 36287144 | Recruitment Challenges of a Colorectal Cancer Screening Dissemination Study. | Nurs Res | 2023 |
| 37763331 | A Preliminary Study Exploring the Relationship between Occupational Health Hazards and Gut Microbiota among Firefighters. | Life (Basel) | 2023 |
| 37843101 | Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials. | Health Technol Assess | 2023 |
| 37657461 | Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial. | Lancet Oncol | 2023 |
| 37645769 | Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization. | Res Sq | 2023 |
| 37986811 | NMR metabolomic modelling of age and lifespan: a multi-cohort analysis. | medRxiv | 2023 |
| 37980767 | Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Gynecol Oncol | 2023 |
| 37147936 | Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. | Proteomics Clin Appl | 2023 |
| 37027390 | A Cultural-Based approach to address substance use among urban Native American young adults. | J Community Psychol | 2023 |
| 36826816 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. | JAMA Netw Open | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37132126 | Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. | BJOG | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37259797 | Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37124335 | Exploring Patients' Needs and Desires for Quality Prenatal Care in Florida, United States. | Int J MCH AIDS | 2023 |
| 37183782 | Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. | Health Technol Assess | 2023 |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 |
| 37302261 | Application of the ConNECT Framework to achieve digital health equity. | Nurs Outlook | 2023 |
| 37296935 | Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India. | Cancers (Basel) | 2023 |
| 37105163 | How hairfall saved the patient from cancer twice - A postmenopausal patient with synchronous endometrial and endocervical carcinomas presenting with endocrine symptoms. | Post Reprod Health | 2023 |
| 37353762 | Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review. | Harm Reduct J | 2023 |
| 36670203 | Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning. | Commun Med (Lond) | 2023 |
| 37657461 | Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial. | Lancet Oncol | 2023 |
| 37843101 | Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials. | Health Technol Assess | 2023 |
| 37986811 | NMR metabolomic modelling of age and lifespan: a multi-cohort analysis. | medRxiv | 2023 |
| 37645769 | Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization. | Res Sq | 2023 |
| 37980767 | Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Gynecol Oncol | 2023 |
| 37763331 | A Preliminary Study Exploring the Relationship between Occupational Health Hazards and Gut Microbiota among Firefighters. | Life (Basel) | 2023 |
| 37353762 | Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review. | Harm Reduct J | 2023 |
| 37259797 | Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37124335 | Exploring Patients' Needs and Desires for Quality Prenatal Care in Florida, United States. | Int J MCH AIDS | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37183782 | Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. | Health Technol Assess | 2023 |
| 37147936 | Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. | Proteomics Clin Appl | 2023 |
| 37105163 | How hairfall saved the patient from cancer twice - A postmenopausal patient with synchronous endometrial and endocervical carcinomas presenting with endocrine symptoms. | Post Reprod Health | 2023 |
| 37302261 | Application of the ConNECT Framework to achieve digital health equity. | Nurs Outlook | 2023 |
| 37132126 | Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. | BJOG | 2023 |
| 37296935 | Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India. | Cancers (Basel) | 2023 |
| 37027390 | A Cultural-Based approach to address substance use among urban Native American young adults. | J Community Psychol | 2023 |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36826816 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. | JAMA Netw Open | 2023 |
| 36670203 | Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning. | Commun Med (Lond) | 2023 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |